Biosensors International Group Ltd., a Singapore-based medical device maker, is scaling back its Newport Beach operations.
The company plans to cut or transfer about 80 Southern California workers with the bulk of the affected jobs at its U.S. headquarters in Newport Beach.
Biosensors employs about 65 people in Newport Beach. The company also has operations in La Jolla, which could see a gain of jobs from Orange County as well as some cuts or transfers.
In all, Biosensors plans to cut 40 to 50 workers.
The company is likely to keep a downsized office in Newport Beach, where Chief Execu-tive Mike Kleine and Chief Financial Of-ficer Kevin Sayer work.
Biosensors makes blood pressure kits, drug-eluting stents and catheters that are used during heart and other surgeries. It counts about 300 workers companywide.
The company is “currently focused on Asia and Europe,” Sayer said in an e-mail.
Neither Sayer nor Kleine were available for further comment last week as both were in Singapore.
The company’s Newport Beach office houses administrative and engineering jobs. La Jolla has the company’s advanced engineering operations.
Biosensors has offered Newport Beach and other workers a chance to transfer to La Jolla and other locations in Europe and Asia, Sayer said.
Biosensors expects some workers won’t choose to stay with the company at its other offices, according to Sayer.
The company has been in Newport Beach for more than four years.
For more on this story, see the May 26 edition of the Business Journal.
